Researchers & Faculty
Japanese
Seiichiro Kano
Department / Course
Hokkaido University of Science Faculty of Pharmaceutical Sciences Department of Pharmacy
Job
Professor
Academic conference presentation
2023/12/15
Effects of adrenaline administration on abnormal electrocardiographic electrical signals and myocardial H-FABP protein expression during anaphylaxis in rats. (The 97th Annual Meeting of the Japanese Pharmacological Society)
2023/05/21
Effects of Adrenaline Administration on Abnormal Electrocardiographic Signals in Anaphylactic-Induced Rats
2023/01/27
Investigation of the inhibitory mechanism of Suramin on ST elevation during anaphylaxis induction. (The 32nd Annual Meeting of Japanese Association of Cardiovascular Pharmacology)
2022/05/21
Effects of Suramin Administration on Connexin 40 and hFABP Expression in the Heart of Rats with Anaphylaxis.
2022/03/07
Effects of Suramin administration on hemodynamics during myocardial ischemia induced by anaphylaxis in rats. (Japan Pharmaceutical Society)
2021/03/28
Effects of Adrenaline and Diltiazem administration on myocardial tissue Connexin 40 and HIF -1 Alpha expression in myocardial ischemia caused by anaphylaxis induction in rats.
2010/06
Inhibitory mechanism of TNF-alpha-induced serine phosphorylation of IRS-1 mediated by AMP activated protein kinase in 3T3-L1 adipocytes (ADA’s 70th Scientific Sessions, Orlando Florida USA)
2009/06
Atorvastatin affects insulin signal transduction by inhibiting Rho GTPase in 3T3L1 adipocytes (ADA’s 69th Scientific Sessions, New Orleans, Louisiana USA)
2003/05
Antiatherogenic effects of a novel selective acyl-CoA: Cholesterol acyltransferase-1 inhibitor, OT-13398, in the rat carotid artery with experimental atherosclerosis. (4th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology)
2002/07
Discrepancy between effects of lipophilic statins on angiographic regression and on cardiac event rates. (14th World Congress of Pharmacology, San Francisco, USA 2002 July)
2002/07
Effect of RNH-6270, a novel angiotensin II type 1 receptor (AT1) antagonist, on stunned myocardium in dogs. (14th World Congress of Pharmacology, San Francisco, USA 2002 July)
1996/11
Limitation of stunning in dog myocardium by nucleoside and nucleotide mixture, OG-VI (The XIII Meeting of the Japanese Section of ISHR、千葉)
1994/07
Limitation of stunning in dog myocardium by nucleoside and nucleotide mixture, OG-VI. (12th International Congress of Pharmacology, Montreal, Canada)
1994/05
Modification of tumor necrosis factor (TNF) production and survival rate by a nucleoside mixture in lipopolysaccharide-injected rats. (8th International Symposium Purine and Pyrimidine Metabolism, Bloomington, USA)
1993/09
A mixture of nucleosides and a nucleotide (OG-VI) as a nutrient of artificial nutrition assisting in the maintenance of intestinal barrier function. (15th International Congress of Nutrition, Adelaide, Australia)